Ad
related to: bristol-myers squibb
Search results
Bill honoring murder victim Amanda Dabrowski moves one step closer to law
Worcester Telegram & Gazette via Yahoo News· 2 days agoBOSTON ― A bill that would close a loophole in the state's domestic violence laws sailed through the...
A year ago, Takeda pledged to create local jobs in exchange for $1.8 million in tax breaks. Now,...
The Boston Globe· 14 hours agoThen last week Takeda said in a filing with the state that it planned to lay off 641 employees in...
Terran Biosciences prepares for trials of schizophrenia drug
Clinical Trials Arena via Yahoo Finance· 7 days agoTerran Biosciences is aiming to launch two Phase I trials of its candidate TerXT for patients with...
2 High-Yield Dividend ETFs to Buy to Generate Passive Income
Motley Fool via Yahoo Finance· 4 days agoExchange-traded funds (ETFs) make it super easy to be a passive investor. They offer instant,...
Recursion Pharma Taps Hershberg as Next Chair to Succeed Chavez
Market Watch· 7 days agoRecursion Pharmaceuticals is naming a new chair as Martin Chavez departs after four years at the board's helm. The clinical stage biotechnology company said Friday that it has tapped Dr. Robert ...
3 Blue-Chip Stocks to Buy at 52-Week Lows in May
InvestorPlace· 4 days agoIt may seem risky to look for blue-chip stocks at a 52-week low. Buffett made billions for Berkshire Hathaway (NYSE:BRK-A, BRK-B) applying this logic to...
10 Best Growing Industries To Invest in for 2024
GoBankingRates via AOL· 5 days ago©Shutterstock.com Fast-growing industries often lead to profitable stock trades. The faster a company can grow earnings, the more investors are willing...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 1 day agoFutureBridge, a leading techno-commercial consulting and advisory company focussing on R&D, innovation, strategy, scientific evidence, markets, reimbursement and regulatory aspects, is set to ...
Study: Access to targeted lung cancer drug is cost-prohibitive globally
Medical Xpress· 13 hours agoA new study from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine examined the cost-effectiveness of durvalumab, a targeted immunotherapy for lung cancer ...
All Over the Map? Mechanisms of ICI Acquired Resistance in NSCLC
MedPage Today· 7 days ago"Resistance is futile." What's less debatable, though, is that patients with non-small cell lung...
